The Dual Role of LRP1 in Generation and Clearance of Ab
About the Research Project
Program
Award Type
Standard
Award Amount
$240,000
Active Dates
April 01, 2007 - March 31, 2010
Grant ID
A2007096
Goals
Recent scientific investigations revealed that a receptor, LRP1, present on the outside of the cells in the brain might be involved at the same time in both production and breakdown of Ab. Lately, the applicant of the research project generated mice and cells with a modified LRP1, which can be used to clarify the double role of LRP1 in Ab metabolism.
Summary
Alzheimer’s Disease (AD) is caused by the increasing appearance of abnormal structures in the brain of AD patients, named senile plaques. These plaques consist mainly out of aggregates of a small peptide, Ab, which arises from cleavage from a larger protein. Ab is also present in the brain of healthy people, but for some reason the amount of Ab in the brain goes strongly up and it is deposited in the senile plaques in AD patients. It seems that the normal balance between production and breakdown of Ab, in scientific terms Ab metabolism, is disturbed. Recent scientific investigations revealed that a receptor, LRP1, present on the outside of the cells in the brain might be involved at the same time in both production and breakdown of Ab. Lately, the applicant of the research project generated mice and cells with a modified LRP1, which can be used to clarify the double role of LRP1 in Ab metabolism. It is the strong belief of the applicant that this scientific research will result in essential additional knowledge on the role of LRP1 in the balance of production and breakdown of Ab. This could eventually contribute to new approaches for a treatment for AD.
Related Grants
Alzheimer's Disease Research
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
Alzheimer's Disease Research
Abca1 Regulates Lipid Metabolism and Tau Pathology in P301S/ApoE4 Mice
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Alexandra Litvinchuk, PhD
Current Organization
Washington University in St. Louis
Abca1 Regulates Lipid Metabolism and Tau Pathology in P301S/ApoE4 Mice
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Alexandra Litvinchuk, PhD
Current Organization
Washington University in St. Louis
Alzheimer's Disease Research
Dysfunction of the Regulation of Cerebral Blood Flow in Alzheimer Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Antoine Anfray, PhD
Current Organization
Weill Medical College of Cornell University
Dysfunction of the Regulation of Cerebral Blood Flow in Alzheimer Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Antoine Anfray, PhD
Current Organization
Weill Medical College of Cornell University